These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33867899)

  • 1. In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins.
    Wong FC; Ong JH; Kumar DT; Chai TT
    Int J Pept Res Ther; 2021; 27(3):1837-1847. PubMed ID: 33867899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An
    Wong FC; Ong JH; Chai TT
    Phytomed Plus; 2021 Feb; 1(1):100016. PubMed ID: 35403082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.
    Prasertsuk K; Prongfa K; Suttiwanich P; Harnkit N; Sangkhawasi M; Promta P; Chumnanpuen P
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs.
    Bansal P; Kumar R; Singh J; Dhanda S
    J Proteins Proteom; 2021; 12(3):177-184. PubMed ID: 34456530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening of phytoconstituents from miracle herb
    Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
    Shah M; Yamin R; Ahmad I; Wu G; Jahangir Z; Shamim A; Nawaz H; Nishan U; Ullah R; Ali EA; Sheheryar ; Chen K
    PLoS One; 2024; 19(1):e0294769. PubMed ID: 38175855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of nut protein-derived peptides against SARS-CoV-2 spike protein and main protease.
    Zhao W; Xu G; Yu Z; Li J; Liu J
    Comput Biol Med; 2021 Nov; 138():104937. PubMed ID: 34655899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides.
    Moradi M; Golmohammadi R; Najafi A; Moosazadeh Moghaddam M; Fasihi-Ramandi M; Mirnejad R
    Int J Pept Res Ther; 2022; 28(1):24. PubMed ID: 34903959
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19.
    Gurung AB; Ali MA; Lee J; El-Zaidy M; Aljowaie RM; Almutairi SM
    PLoS One; 2022; 17(6):e0268919. PubMed ID: 35657783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
    Li D; Luan J; Zhang L
    Biochem Biophys Res Commun; 2021 Jan; 538():72-79. PubMed ID: 33276953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 17. Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran.
    Harnkit N; Khongsonthi T; Masuwan N; Prasartkul P; Noikaew T; Chumnanpuen P
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease.
    Miwa K; Guo Y; Hata M; Hirano Y; Yamamoto N; Hoshino T
    Chem Pharm Bull (Tokyo); 2023; 71(12):897-905. PubMed ID: 38044142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from
    Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S
    J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
    Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
    J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.